Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it. Issue 9 (September 2021)
- Record Type:
- Journal Article
- Title:
- Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it. Issue 9 (September 2021)
- Main Title:
- Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it
- Authors:
- Liang, Xiao
Zheng, Junhao
Xu, Junjie
Tao, Liye
Cai, Jingwei
Liang, Yuelong
Feng, Xu
Cai, Xiujun - Abstract:
- Abstract: Background: Laparoscopic anatomical resection (LAR) is a highly challenging procedure. This study aimed to describe our experience of the LAR with an indocyanine green fluorescence negative staining (ICGNS) by the Glissonean pedicle transection (Takasaki) approach. Methods: From April 2017 to December 2019, 43 consecutive patients underwent LAR with ICGNS strategy in our medical team. The details of the ICGNS strategy were described. The demographic and clinicopathological data of the included patients were retrospectively analyzed. Results: The extent of resections included right hemihepatectomy ( n = 12), left hemihepatectom ( n = 4), left lateral sectionectomy ( n = 3), Right anterior sectionectomy ( n = 3), Right posterior sectionectomy ( n = 6), central hepatectomy ( n = 2), single anterolateral segmentectomy ( n = 5), single posterosuperior segmentectomy ( n = 6), and bisegmentectomy ( n = 2). The mean operation time was 212 ± 53 min, and the median estimated blood loss was 200 (100–300) ml. The overall complication rate was 30.2% (grade I, 14%; grade II, 14%; grade III, 2.3%). The median duration of postoperative hospital stay was 6 (4–7) days. Conclusion: ICGNS is a safe and feasible LAR strategy that greatly facilitates selecting the liver transection plane, although its benefits need to be verified by large-sample comparative studies.
- Is Part Of:
- HPB. Volume 23:Issue 9(2021)
- Journal:
- HPB
- Issue:
- Volume 23:Issue 9(2021)
- Issue Display:
- Volume 23, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 23
- Issue:
- 9
- Issue Sort Value:
- 2021-0023-0009-0000
- Page Start:
- 1392
- Page End:
- 1399
- Publication Date:
- 2021-09
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.hpb.2021.01.014 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19605.xml